However, in IDH‐mutant gliomas, the mutated enzyme acquires a neomorphic function, converting α‐KG to R‐2‐hydroxyglutarate (R‐2‐HG) [25, 26, 27]. The gene discussed is IDH2; the disease is central nervous system cancer.